Review article · 2024 · Open access

Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives

Daria Krawczuk, Agnieszka Kulczyńska‐Przybik, Barbara Mroczko

International Journal of Molecular Sciences, 25(15), 8132 · Published 25 July 2024 · DOI 10.3390/ijms25158132

Open PDFView at the publisherCite this paper

In brief

“Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives” is a 2024 review article by Daria Krawczuk and 2 co-authors, published in International Journal of Molecular Sciences. OpenAlex counts 30 citations as of 19 November 2026, which puts it in the top 7% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at International Journal of Molecular Sciences.

Citations
30
Most cited in
2025 (15)
Field-weighted impact
1.43
References
102
Authors
3

Abstract

Neurodegenerative diseases are a group of complex diseases characterized by a progressive loss of neurons and degeneration in different areas of the nervous system. They share similar mechanisms, such as neuroinflammation, oxidative stress, and mitochondrial injury, resulting in neuronal loss. One of the biggest challenges in diagnosing neurodegenerative diseases is their heterogeneity. Clinical symptoms are usually present in the advanced stages of the disease, thus it is essential to find optimal biomarkers that would allow early diagnosis. Due to the development of ultrasensitive methods analyzing proteins in other fluids, such as blood, huge progress has been made in the field of biomarkers for neurodegenerative diseases. The application of protein biomarker measurement has significantly influenced not only diagnosis but also prognosis, differentiation, and the development of new therapies, as it enables the recognition of early stages of disease in individuals with preclinical stages or with mild symptoms. Additionally, the introduction of biochemical markers into routine clinical practice may improve diagnosis and allow for a stratification group of people with higher risk, as well as an extension of well-being since a treatment could be started early. In this review, we focus on blood biomarkers, which could be potentially useful in the daily medical practice of selected neurodegenerative diseases.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Krawczuk, D., Kulczyńska‐Przybik, A., & Mroczko, B. (2024). Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives. International Journal of Molecular Sciences, 25(15), 8132. https://doi.org/10.3390/ijms25158132

MLA 9

Krawczuk, Daria, et al. “Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives.” International Journal of Molecular Sciences, vol. 25, no. 15, 2024, p. 8132. https://doi.org/10.3390/ijms25158132.

Chicago

Krawczuk, Daria, Agnieszka Kulczyńska‐Przybik, and Barbara Mroczko. 2024. “Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives.” International Journal of Molecular Sciences 25 (15): 8132. https://doi.org/10.3390/ijms25158132.

Harvard

Krawczuk, D., Kulczyńska‐Przybik, A. and Mroczko, B. (2024) ‘Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives’, International Journal of Molecular Sciences, 25(15), p. 8132. doi:10.3390/ijms25158132.

IEEE

D. Krawczuk, A. Kulczyńska‐Przybik, and B. Mroczko, “Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives,” International Journal of Molecular Sciences, vol. 25, no. 15, p. 8132, 2024, doi: 10.3390/ijms25158132.

BibTeX

@article{krawczuk2024clinical,
  title     = {{Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives}},
  author    = {Krawczuk, Daria and Kulczyńska‐Przybik, Agnieszka and Mroczko, Barbara},
  journal   = {International Journal of Molecular Sciences},
  year      = {2024},
  volume    = {25},
  number    = {15},
  pages     = {8132},
  doi       = {10.3390/ijms25158132},
  url       = {https://doi.org/10.3390/ijms25158132}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202422
20251515
20261313

Its field-weighted citation impact is 1.43: it has been cited 1.43 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research

  • neurodegenerative diseases
  • blood biomarkers
  • protein biomarkers
  • early diagnosis
  • neuroinflammation
  • oxidative stress
  • mitochondrial injury
  • disease heterogeneity

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Krawczuk, D., Kulczyńska‐Przybik, A., & Mroczko, B. (2024). Clinical Application of Blood Biomarkers in Neurodegenerative Diseases—Present and Future Perspectives. International Journal of Molecular Sciences, 25(15), 8132. https://doi.org/10.3390/ijms25158132

How many times has this paper been cited?

30 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal of Molecular Sciences: sign in and open the PDF from this page.

Who wrote this paper?

Daria Krawczuk, Agnieszka Kulczyńska‐Przybik, Barbara Mroczko.

What is the DOI of this paper?

10.3390/ijms25158132, permanently at https://doi.org/10.3390/ijms25158132. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.